| Symbol |
Name |
|
ADA
|
adenosine deaminase
|
|
ADH5
|
alcohol dehydrogenase 5 (class III), chi polypeptide
|
|
ADM
|
adrenomedullin
|
|
ADRA1A
|
adrenoceptor alpha 1A
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB3
|
adrenoceptor beta 3
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALDOC
|
aldolase C, fructose-bisphosphate
|
|
ALOX12
|
arachidonate 12-lipoxygenase
|
|
AMFR
|
autocrine motility factor receptor, E3 ubiquitin protein ligase
|
|
AMH
|
anti-Mullerian hormone
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOD
|
apolipoprotein D
|
|
APOE
|
apolipoprotein E
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP8A2
|
ATPase, aminophospholipid transporter, class I, type 8A, member 2
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKB
|
aurora kinase B
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C2ORF40
|
chromosome 2 open reading frame 40
|
|
CACYBP
|
calcyclin binding protein
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CANX
|
calnexin
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CD86
|
CD86 molecule
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CISD2
|
CDGSH iron sulfur domain 2
|
|
CNP
|
2',3'-cyclic nucleotide 3' phosphodiesterase
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CTC1
|
CTS telomere maintenance complex component 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTSC
|
cathepsin C
|
|
CTSV
|
cathepsin V
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
DCN
|
decorin
|
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
|
DNAJA3
|
DnaJ (Hsp40) homolog, subfamily A, member 3
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
ENG
|
endoglin
|
|
ENO3
|
enolase 3 (beta, muscle)
|
|
EPO
|
erythropoietin
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXG1
|
forkhead box G1
|
|
GJB6
|
gap junction protein, beta 6, 30kDa
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
|
GPX1
|
glutathione peroxidase 1
|
|
GPX4
|
glutathione peroxidase 4
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GSN
|
gelsolin
|
|
GSS
|
glutathione synthetase
|
|
HELT
|
helt bHLH transcription factor
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HTR2A
|
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
|
|
HTT
|
huntingtin
|
|
HYAL2
|
hyaluronoglucosaminidase 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL6
|
interleukin 6
|
|
ILK
|
integrin-linked kinase
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IREB2
|
iron-responsive element binding protein 2
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JUN
|
jun proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KAT6A
|
K(lysine) acetyltransferase 6A
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KL
|
klotho
|
|
KRT14
|
keratin 14, type I
|
|
KRT16
|
keratin 16, type I
|
|
KRT25
|
keratin 25, type I
|
|
KRT33B
|
keratin 33B, type I
|
|
KRT83
|
keratin 83, type II
|
|
KRTAP4-3
|
keratin associated protein 4-3
|
|
KRTAP4-5
|
keratin associated protein 4-5
|
|
KRTAP4-8
|
keratin associated protein 4-8
|
|
KRTAP4-9
|
keratin associated protein 4-9
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
|
LOC100996750
|
keratin-associated protein 4-7
|
|
LONP1
|
lon peptidase 1, mitochondrial
|
|
LOXL2
|
lysyl oxidase-like 2
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
MADCAM1
|
mucosal vascular addressin cell adhesion molecule 1
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MBP
|
myelin basic protein
|
|
MGEA5
|
meningioma expressed antigen 5 (hyaluronidase)
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MME
|
membrane metallo-endopeptidase
|
|
MNT
|
MAX network transcriptional repressor
|
|
MORC3
|
MORC family CW-type zinc finger 3
|
|
MPO
|
myeloperoxidase
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NDUFS6
|
NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase)
|
|
NOX4
|
NADPH oxidase 4
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NSMCE2
|
non-SMC element 2, MMS21 homolog (S. cerevisiae)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUP62
|
nucleoporin 62kDa
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
PAX2
|
paired box 2
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
|
PML
|
promyelocytic leukemia
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PRELP
|
proline/arginine-rich end leucine-rich repeat protein
|
|
PRKCD
|
protein kinase C, delta
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTH1R
|
parathyroid hormone 1 receptor
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RETN
|
resistin
|
|
ROMO1
|
reactive oxygen species modulator 1
|
|
RPN2
|
ribophorin II
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
SCAP
|
SREBF chaperone
|
|
SEC63
|
SEC63 homolog (S. cerevisiae)
|
|
SERP1
|
stress-associated endoplasmic reticulum protein 1
|
|
SERPINA7
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRT1
|
sirtuin 1
|
|
SIRT3
|
sirtuin 3
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC32A1
|
solute carrier family 32 (GABA vesicular transporter), member 1
|
|
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate cotransporter), member 2
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SMC5
|
structural maintenance of chromosomes 5
|
|
SMC6
|
structural maintenance of chromosomes 6
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS2
|
suppressor of cytokine signaling 2
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SPEF2
|
sperm flagellar 2
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRR
|
serine racemase
|
|
TACR3
|
tachykinin receptor 3
|
|
TBX2
|
T-box 2
|
|
TBX3
|
T-box 3
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TH
|
tyrosine hydroxylase
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TPRA1
|
transmembrane protein, adipocyte asscociated 1
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TSPO
|
translocator protein (18kDa)
|
|
TYMS
|
thymidylate synthetase
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UCP3
|
uncoupling protein 3 (mitochondrial, proton carrier)
|
|
ULK3
|
unc-51 like kinase 3
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
ZMIZ1
|
zinc finger, MIZ-type containing 1
|
